Back to Authors

Goeldner, Rainer-Georg

0009-0001-2918-8946

A5052219607 | I1330995197

Mayo Clinic

Boehringer Ingelheim (Germany)

Citations 1

Effects of nintedanib on progression of ILD in patients with fibrosing ILDs and a progressive phenotype: further analyses of the INBUILD trial

Pneumologie | October 26, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0041-1723315